Skip to main content

Eledon Pharmaceuticals Inc. Common Stock (ELDN)

About The Company

ELDN Stock Market Logo

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company’s lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

IPO Year Sector Industry
2014 Health Care Biotechnology: Pharmaceutical Preparations

Eledon Pharmaceuticals Inc. (ELDN) Latest News

Company Contact & Address (ELDN)

Corporate Headquarters Phone Website
United States
+1 949 238-8090 Official ELDN Website

ELDN Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ELDN

Jobs & Employment at Eledon Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page Employment & Jobs at Eledon Pharmaceuticals Inc. (ELDN)

Related & Similar Stock Symbols

WBEV Stock Market Price & News


Winc Inc. Common Stock

GSMGW Stock Market Price & News


Glory Star New Media Group Holdings Limited …

SFIX Stock Market Price & News


Stitch Fix Inc. Class A Common Stock